Celtic Renewables’ patented technology converts low-value biological residues into high-value, low-carbon sustainable chemicals & biofuels. Construction of their flagship plant is complete & their first customer; Caldic, who turned over almost €900m last year, is on board. Over £35m in funding raised to date.
At Celtic Renewables, our proposition is simple: we take residual by-products, initially from the whisky industry, which are produced in large volumes & problematic to dispose of and use our internationally patented process to convert them into high-value low carbon products, namely Acetone, Butanol, Ethanol & animal feed; markets set to be worth £130bn by 2025. These products play an important role in our daily lives & are used in pharmaceuticals, cosmetics, food, hygiene products and advanced biofuels.
Since our raise in November 2020:
- We’ve completed construction of our flagship biorefinery in Grangemouth, Scotland & have now entered the production phase.
- Our first customer, Caldic, a major global distributor for the food, pharma & personal care industries (approx. €900m 2020 revenue), has signed a 3-year multi million pound contract and will distribute >50% of the solvents produced by the 1st plant, we have a number of LOIs in place with other global chemical companies
- Our biochemicals have been independently verified as carbon negative compared to petrochemical equivalents over their lifetime
We are now raising investment to begin to build & launch our next, larger-scale plants with discussions well underway with a number of multinational companies, including a major F&B company that would provide brand new types of feedstocks, on which we’ve held successful trials.